148 related articles for article (PubMed ID: 33632592)
1. Lifetime Costs of Hospitalised Cardiovascular Disease in Australia: An Incidence-Based Estimate.
Nghiem S; Afoakwah C; Byrnes J; Scuffham P
Heart Lung Circ; 2021 Aug; 30(8):1207-1212. PubMed ID: 33632592
[TBL] [Abstract][Full Text] [Related]
2. The health care and societal costs of inherited retinal diseases in Australia: a microsimulation modelling study.
Schofield D; Kraindler J; Tan O; Shrestha RN; West S; Hart N; Tan L; Ma A; Grigg JR; Jamieson RV
Med J Aust; 2023 Jul; 219(2):70-76. PubMed ID: 37301731
[TBL] [Abstract][Full Text] [Related]
3. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS).
Dewey HM; Thrift AG; Mihalopoulos C; Carter R; Macdonell RA; McNeil JJ; Donnan GA
Stroke; 2001 Oct; 32(10):2409-16. PubMed ID: 11588334
[TBL] [Abstract][Full Text] [Related]
4. The value of maternity care in Queensland, 2012-18, based on an analysis of administrative data: a retrospective observational study.
Callander EJ; Enticott JC; Eklom B; Gamble J; Teede HJ
Med J Aust; 2023 Dec; 219(11):535-541. PubMed ID: 37940105
[TBL] [Abstract][Full Text] [Related]
5. Academic achievement and productivity losses associated with speech, language and communication needs.
Cronin P; Reeve R; McCabe P; Viney R; Goodall S
Int J Lang Commun Disord; 2020 Sep; 55(5):734-750. PubMed ID: 32687245
[TBL] [Abstract][Full Text] [Related]
6. Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029.
Marquina C; Talic S; Vargas-Torres S; Petrova M; Abushanab D; Owen A; Lybrand S; Thomson D; Liew D; Zomer E; Ademi Z
Eur J Prev Cardiol; 2022 May; 29(8):1212-1219. PubMed ID: 33686414
[TBL] [Abstract][Full Text] [Related]
7. Societal cost of childhood intellectual disability in Australia.
Arora S; Goodall S; Viney R; Einfeld S
J Intellect Disabil Res; 2020 Jul; 64(7):524-537. PubMed ID: 32329168
[TBL] [Abstract][Full Text] [Related]
8. Health care service use by people diagnosed with invasive melanoma in Queensland: a benefit incidence analysis.
Lindsay D; Whiteman DC; Olsen CM; Gordon LG
Med J Aust; 2023 Nov; 219(9):417-422. PubMed ID: 37807891
[TBL] [Abstract][Full Text] [Related]
9. Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry.
Ademi Z; Liew D; Hollingsworth B; Steg PG; Bhatt DL; Reid CM;
Am J Cardiovasc Drugs; 2010; 10(2):85-94. PubMed ID: 20334445
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
[TBL] [Abstract][Full Text] [Related]
11. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
[TBL] [Abstract][Full Text] [Related]
12. Cost of gastroenteritis in Australia: A healthcare perspective.
Barker SF; Zomer E; O'Toole J; Sinclair M; Gibney K; Liew D; Leder K
PLoS One; 2018; 13(4):e0195759. PubMed ID: 29649285
[TBL] [Abstract][Full Text] [Related]
13. The economic burden of myalgic encephalomyelitis/chronic fatigue syndrome in Australia.
Zhao T; Cox IA; Ahmad H; Campbell JA; Hensher M; Palmer AJ; Kelly RM; Rogerson MJ; Wills K; de Graaff B
Aust Health Rev; 2023 Dec; 47(6):707-715. PubMed ID: 38011828
[TBL] [Abstract][Full Text] [Related]
14. Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia.
Callander E; Bates N; Lindsay D; Larkins S; Topp SM; Cunningham J; Sabesan S; Garvey G
Int J Equity Health; 2019 Feb; 18(1):32. PubMed ID: 30755217
[TBL] [Abstract][Full Text] [Related]
15. Economic impact of delirium in Australia: a cost of illness study.
Pezzullo L; Streatfeild J; Hickson J; Teodorczuk A; Agar MR; Caplan GA
BMJ Open; 2019 Sep; 9(9):e027514. PubMed ID: 31530588
[TBL] [Abstract][Full Text] [Related]
16. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.
Campbell HE; Kurinczuk JJ; Heazell A; Leal J; Rivero-Arias O
BJOG; 2018 Jan; 125(2):108-117. PubMed ID: 29034559
[TBL] [Abstract][Full Text] [Related]
17. Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS).
Dewey HM; Thrift AG; Mihalopoulos C; Carter R; Macdonell RA; McNeil JJ; Donnan GA
Stroke; 2003 Oct; 34(10):2502-7. PubMed ID: 12970517
[TBL] [Abstract][Full Text] [Related]
18. Lifetime direct costs of stroke for indigenous patients adjusted for comorbidities.
Zhao Y; Condon J; Lawton P; He V; Cadilhac DA
Neurology; 2016 Aug; 87(5):458-65. PubMed ID: 27371489
[TBL] [Abstract][Full Text] [Related]
19. Cost of high prevalence mental disorders: Findings from the 2007 Australian National Survey of Mental Health and Wellbeing.
Lee YC; Chatterton ML; Magnus A; Mohebbi M; Le LK; Mihalopoulos C
Aust N Z J Psychiatry; 2017 Dec; 51(12):1198-1211. PubMed ID: 28565923
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of severe cardiovascular diseases in Brazil: an estimate based on secondary data.
Azambuja MI; Foppa M; Maranhão MF; Achutti AC
Arq Bras Cardiol; 2008 Sep; 91(3):148-55, 163-71. PubMed ID: 18853056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
